VISION
Tackling "Undruggable" Targets
RAtionally Develop Cell-Penetrating Peptide Therapeutics to RADically Enhance Patient Therapy
About RAD Therapeutics
Our Mission
Our Strategy
Our Strategy
RAtionally Develop Cell-Penetrating Peptide Therapeutics
against challenging targets, to RADically improve treatment of serious diseases
Our Strategy
Our Strategy
Our Strategy
Harness the high selectivity and low toxicity of peptides, discover and engineer cell-penetrating, stable and optimized peptides, to create transformational proprietary therapeutics against validated intracellular targets that are considered "undruggable"
Our Path
Our Strategy
Our Path
We have established POC with our lead peptide against a quintessential pan-cancer oncogene, SURVIVIN, and its protein-protein interactions network
We are ramping up to streamline discovery of a pipeline of proprietary novel peptide therapeutics and to advance development of our lead product towards clinical trials
Tackling Difficult to Treat Serious Diseases
At RAD Therapeutics, our mission is to RADically improve the lives of patients through RAtional Development of innovative cell-penetrating peptide therapeutics.